title: Primate terminal complement inhibitor homologues of human CD59.
authors.affiliation: Alexion Pharmaceuticals, Inc., New Haven, CT 06511-1968.
authors.forename: W L
authors.initials: WL
authors.lastname: Fodor
authors.forename: S A
authors.initials: SA
authors.lastname: Rollins
authors.forename: S
authors.initials: S
authors.lastname: Bianco-Caron
authors.forename: W V
authors.initials: WV
authors.lastname: Burton
authors.forename: E R
authors.initials: ER
authors.lastname: Guilmette
authors.forename: R P
authors.initials: RP
authors.lastname: Rother
authors.forename: G B
authors.initials: GB
authors.lastname: Zavoico
authors.forename: S P
authors.initials: SP
authors.lastname: Squinto
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000235:genetics*; D001483:Base Sequence; D018957:CD59 Antigens; D018076:DNA, Complementary; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics*; D008969:Molecular Sequence Data; D011323:Primates / Q000235:genetics; D016415:Sequence Alignment; D012689:Sequence Homology, Nucleic Acid
chemical_list: D015703:Antigens, CD; D018957:CD59 Antigens; D018076:DNA, Complementary; D008562:Membrane Glycoproteins